Twin Vee amends USFM merger terms, boosts USFM holders’ stake to 93%
Bitget2026/10/08 11:00USFM revised its merger terms with Twin Vee PowerCats, shifting post-closing ownership to 93% USFM holders, 7% Twin Vee holders. Reworked structure uses a new Texas parent, Twin Vee Holdco, which will own USFM and Twin Vee as separate wholly owned units. USFM must use reasonable best efforts to raise up to USD 5 million in a PIPE financing. Twin Vee plans a CVR trust that will hold the marine business, distributing non-transferable CVRs to pre-closing Twin Vee holders. Closing targeted for Q4 2026 or Q1 2027, subject to customary conditions including disinterested shareholder approval. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Twin Vee PowerCats Co. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610080700ACCESSWRNAPR_____1233923) on October 08, 2026, and is solely responsible for the information contained therein.
- USFM revised its merger terms with Twin Vee PowerCats, shifting post-closing ownership to 93% USFM holders, 7% Twin Vee holders.
- Reworked structure uses a new Texas parent, Twin Vee Holdco, which will own USFM and Twin Vee as separate wholly owned units.
- USFM must use reasonable best efforts to raise up to USD 5 million in a PIPE financing.
- Twin Vee plans a CVR trust that will hold the marine business, distributing non-transferable CVRs to pre-closing Twin Vee holders.
- Closing targeted for Q4 2026 or Q1 2027, subject to customary conditions including disinterested shareholder approval.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
